Indivior Unit Files Lawsuits In U.S. To Protect SUBOXONE Film Patent

(RTTNews) - Indivior plc (INDV.L) announced its U.S. subsidiary, Indivior Inc., has filed patent lawsuits against Dr. Reddy's, Actavis, Par, Alvogen, Teva, and Mylan for infringement of United States Patent No. 9,687,454 relating to their respective proposed generic versions of the company's SUBOXONE Sublingual Film product. The lawsuits allege that these companies infringe the '454 patent, which was issued on June 27, 2017.

Shaun Thaxter, CEO of Indivior, said, "We are also preparing our appeal against the recent decision in the lawsuit against Dr. Reddy's (pending in the U.S. District Court for the District of Delaware), and expect to file our appeal with the U.S. Court of Appeals for the Federal Circuit shortly after the District Court judgement is entered."